Nitta RT - Search Results

1

Development of an EGFRvIII specific recombinant antibody.

Gupta P, Han SY, Holgado-Madruga M, Mitra SS, Li G, Nitta RT, Wong AJ. Gupta P, et al. Among authors: nitta rt. BMC Biotechnol. 2010 Oct 7;10:72. doi: 10.1186/1472-6750-10-72. BMC Biotechnol. 2010. PMID: 20925961 Free PMC article.

2

Constitutive activity of JNK2 alpha2 is dependent on a unique mechanism of MAPK activation.

Nitta RT, Chu AH, Wong AJ. Nitta RT, et al. J Biol Chem. 2008 Dec 12;283(50):34935-45. doi: 10.1074/jbc.M804970200. Epub 2008 Oct 21. J Biol Chem. 2008. PMID: 18940813 Free PMC article.

3

The role of the c-Jun N-terminal kinase 2-α-isoform in non-small cell lung carcinoma tumorigenesis.

Nitta RT, Del Vecchio CA, Chu AH, Mitra SS, Godwin AK, Wong AJ. Nitta RT, et al. Oncogene. 2011 Jan 13;30(2):234-44. doi: 10.1038/onc.2010.414. Epub 2010 Sep 27. Oncogene. 2011. PMID: 20871632 Free PMC article.

4

Measuring the constitutive activation of c-Jun N-terminal kinase isoforms.

Nitta RT, Badal SS, Wong AJ. Nitta RT, et al. Methods Enzymol. 2010;484:531-48. doi: 10.1016/B978-0-12-381298-8.00026-5. Methods Enzymol. 2010. PMID: 21036249 Free PMC article.

5

The invasive nature of glioblastoma.

Nitta RT, Li G. Nitta RT, et al. World Neurosurg. 2013 Sep-Oct;80(3-4):279-80. doi: 10.1016/j.wneu.2011.09.036. Epub 2011 Nov 7. World Neurosurg. 2013. PMID: 22120249 No abstract available.

6

Expression of epidermal growth factor variant III (EGFRvIII) in pediatric diffuse intrinsic pontine gliomas.

Li G, Mitra SS, Monje M, Henrich KN, Bangs CD, Nitta RT, Wong AJ. Li G, et al. Among authors: nitta rt. J Neurooncol. 2012 Jul;108(3):395-402. doi: 10.1007/s11060-012-0842-3. Epub 2012 Mar 2. J Neurooncol. 2012. PMID: 22382786 Free PMC article.

7

Epidermal growth factor receptor variant III contributes to cancer stem cell phenotypes in invasive breast carcinoma.

Del Vecchio CA, Jensen KC, Nitta RT, Shain AH, Giacomini CP, Wong AJ. Del Vecchio CA, et al. Among authors: nitta rt. Cancer Res. 2012 May 15;72(10):2657-71. doi: 10.1158/0008-5472.CAN-11-2656. Epub 2012 Mar 14. Cancer Res. 2012. PMID: 22419663

8

Pathology: commonly monitored glioblastoma markers: EFGR, EGFRvIII, PTEN, and MGMT.

Camara-Quintana JQ, Nitta RT, Li G. Camara-Quintana JQ, et al. Among authors: nitta rt. Neurosurg Clin N Am. 2012 Apr;23(2):237-46, viii. doi: 10.1016/j.nec.2012.01.011. Epub 2012 Feb 22. Neurosurg Clin N Am. 2012. PMID: 22440867 Review.

9

Casein kinase 2α regulates glioblastoma brain tumor-initiating cell growth through the β-catenin pathway.

Nitta RT, Gholamin S, Feroze AH, Agarwal M, Cheshier SH, Mitra SS, Li G. Nitta RT, et al. Oncogene. 2015 Jul;34(28):3688-99. doi: 10.1038/onc.2014.299. Epub 2014 Sep 22. Oncogene. 2015. PMID: 25241897 Free PMC article.

10

Casein Kinase 2: a novel player in glioblastoma therapy and cancer stem cells.

Agarwal M, Nitta RT, Li G. Agarwal M, et al. Among authors: nitta rt. J Mol Genet Med. 2013 Dec 9;8(1):1000094. doi: 10.4172/1747-0862.1000094. J Mol Genet Med. 2013. PMID: 25264454 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

28 results

Search Page

Filters